AzTrials
AzTrials

Total Hip SurgeryNCT05600244

PENG vs. QLB vs. Lumbar ESPB in Total Hip Surgery

A study testing PENG block Technique, Lumbar ESPB Technique and Transmuscular QLB-t block Technique in people with Total Hip Surgery and Pericapsular Nerve, run by Kafrelsheikh University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to compare between Pericapsular Nerve Group Block, Erector Spinae Plane Block and Quadratus Lumborum Block for managing acute postoperative pain in patients undergoing total hip surgeries under spinal anesthesia. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
PENG block Technique, Lumbar ESPB Technique and Transmuscular QLB-t block Technique
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
15 Dec 2022to 10 Oct 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18-65 years
  • Both genders
  • Body mass index < 40 kg/m^2
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Posted for total hip surgeries under spinal anesthesia

Who cannot join

  • The presence of contraindications or allergy to local anesthetic agents
  • Chronic use of opioids or corticosteroids
  • Infection at the puncture site
  • Coagulopathy
  • Psychiatric disorders (dementia or cognitive impairment.

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Mohammad Fouad Algyar

    Tanta, ElGharbiaa, 31511

    Mohammad F Algyar, MD, 00201111645345, mohammad.algaiar@med.kfs.edu.eg

    Recruiting

Other trials in Egypt

About this study

Official title: Comparison of Pericapsular Nerve Group Block, Quadratus Lumborum Block and Lumbar Erector Spinae Plane Block for Acute Pain Management in Total Hip Surgery: A Randomized Clinical Trial

The aim of this study is to compare between Pericapsular Nerve Group Block, Erector Spinae Plane Block and Quadratus Lumborum Block for managing acute postoperative pain in patients undergoing total hip surgeries under spinal anesthesia.

Read the detailed description

Total hip surgeries are one of the most common major orthopedic procedures to improve patient's functional status and quality of life. However, despite these advantages, the immediate postoperative period can be associated with severe pain that delays mobilization and increases hospital stay and the risk of thromboembolic events.

Various methods are used for postoperative pain management. Intravenous opioid agents are among them, but they may cause undesirable side effects, such as respiratory depression, sedation, constipation, allergic reaction, nausea, and vomiting. Thus, alternative techniques are preferred.

Being tested
PENG block Technique, Lumbar ESPB Technique, Transmuscular QLB-t block Technique

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PENG block TechniqueProcedure or surgery

    A linear probe will be used. Puncture will be performed in a lateromedial direction until the needle tip reached the plane between the iliopsoas tendon and periosteum and between the anterior inferior iliac spine and iliopubic eminence. After a negative aspiration test, 30 ml of bupivacaine 0.25% will be injected in the plane beneath the iliopsoas muscle

  • Lumbar ESPB TechniqueProcedure or surgery

    Using the out-plane technique, a 22G/80-mm block needle will be advanced until it reached the transverse process. 0.5-1 ml of the prepared local anesthetic solution, 30 ml bupivacaine 0.25% will be administered leading to hydrodissection to confirm the correct location. The needle will be repositioned by pulling back a few millimeters if resistance occurs when administering local anesthetic . All local anesthetic will be administered to this location between the transverse process and the erector spinae muscle

  • Transmuscular QLB-t block TechniqueProcedure or surgery

    A convex transducer will be placed in the transverse plane on the flank of the patient cranial to the iliac crest. The 4th lumbar vertebral transverse process, erector spinae muscles, psoas muscle, transverse abdominis muscle, internal and externa oblique muscles, and the quadratus lumborum muscle will be identified. A 15 cm 22G insulated needle will be inserted on the posterior corner of the transducer. 30 ml bupivacaine 0.25% will be administered between the quadratus lumborum and psoas muscles into the fascial plane.

Study groups in NCT05600244
Study groupRoleWhat they receive
PENG block TechniqueExperimentalPatients will receive ultrasound-guided Pericapsular Nerve Group Block using 30 ml bupivacaine 0.25%.
Receives: Procedure: PENG block Technique
Lumbar ESPB TechniqueExperimentalPatients will receive lumbar erector spinae plane block using 30 ml bupivacaine 0.25%
Receives: Procedure: Lumbar ESPB Technique
Transmuscular QLB-t block TechniqueExperimentalPatients will receive transmuscular quadratus lumborum block using 30 ml bupivacaine 0.25%
Receives: Procedure: Transmuscular QLB-t block Technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total amount of rescue analgesia

    Total amount of rescue analgesia in the form of morphine will be recorded

    Measured: 24 hours postoperatively

Secondary outcomes (3)
  1. First analgesic request

    The time to first request of rescue analgesia will be recorded

    Measured: 24 hours Postoperatively

  2. Pain level

    Pain level will be evaluated using numeric rating analogue scale (NRS), which ranges from 0 to 10 points, with 0 indicating no pain, 1-3 indicating mild pain, 4-6 indicating moderate pain, and 7-10 indicating severe pain.

    Measured: 48 hours Postoperatively

  3. Adverse events

    Adverse events will be recorded (e.g., nausea, vomiting, hypotension and bradycardia)

    Measured: 48 hours Postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2022
  2. Study start15 Dec 2022
  3. Primary completion10 Oct 2023 (estimated)
  4. Study completion10 Oct 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05600244
Sponsor's protocol ID
MKSU 50-9-21
Status last verified
Sep 2023
First submitted
26 Oct 2022
Last updated
6 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will be available under a reasonable request from the corresponding author.

Questions about this trial

What is this clinical trial studying?

A study testing PENG block Technique, Lumbar ESPB Technique and Transmuscular QLB-t block Technique in people with Total Hip Surgery and Pericapsular Nerve, run by Kafrelsheikh University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohammad F. Algyar, MD (111645345 ext. +20, mohammad.algaiar@med.kfs.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total amount of rescue analgesia (time frame: 24 hours postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in